Phase I, Randomized, Double-Masked, Placebo-Controlled, Dose-Escalation Study to Evaluate Tolerability, Safety & PK of BID Topical Ocular Application of INO-8875 in Healthy Older-Adult Volunteers
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Trabodenoson (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Adverse reactions
- Sponsors Inotek Pharmaceuticals
- 21 Apr 2016 According to an Inotek Pharmaceuticals media release, results from this trial were published in the Journal of Ocular Pharmacology and Therapeutics.
- 08 Oct 2013 New trial record